Spots Global Cancer Trial Database for bleomycin
Every month we try and update this database with for bleomycin cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Treatment of Liver Metastases With Electrochemotherapy (ECTJ) Phase II | NCT02352259 | Liver Metastase... | Electrochemothe... Cliniporator Vi... Bleomycin PHC 1... | 18 Years - | Institute of Oncology Ljubljana | |
| Paclitaxel, Ifosfamide and Cisplatin (TIP) Versus Bleomycin, Etoposide and Cisplatin (BEP) for Patients With Previously Untreated Intermediate- and Poor-risk Germ Cell Tumors | NCT01873326 | Germ Cell Tumor... | Paclitaxel Ifosfamide Cisplatin Mesna Bleomycin Etoposide | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Combination Chemotherapy Plus Low-Dose Radiation Therapy in Treating Patients With Stage I or Stage IIA Hodgkin's Lymphoma | NCT00026208 | Lymphoma, Hodgk... Lymphoma Hodgkin Disease Lymphoma: Hodgk... | Vincristine Cyclophosphamid... Doxorubicin Prednisone Bleomycin Etoposide Low-dose radiot... | 18 Years - 70 Years | Stanford University | |
| A Phase 1 Study of Brentuximab Vedotin Combined With Multi-Agent Chemotherapy for Hodgkin Lymphoma | NCT01060904 | Disease, Hodgki... | brentuximab ved... doxorubicin vinblastine dacarbazine bleomycin brentuximab ved... | 18 Years - 60 Years | Seagen Inc. | |
| Chemotherapy Plus Reduced Radiotherapy in Intracranial Germinoma | NCT02782754 | Intracranial Ge... | Carboplatin Etoposide Cyclophosphamid... Bleomycin Reduced dose of... | 3 Years - 30 Years | Samsung Medical Center | |
| A Study of Chemotherapy Plus Azidothymidine in the Treatment of Kaposi's Sarcoma in Patients With AIDS | NCT00000987 | Sarcoma, Kaposi HIV Infections | Bleomycin sulfa... Vincristine sul... Doxorubicin hyd... Zidovudine | 13 Years - | National Institute of Allergy and Infectious Diseases (NIAID) | |
| HD21 for Advanced Stages | NCT02661503 | Classical Hodgk... | Bleomycin Etoposide Doxorubicin Cyclophosphamid... Vincristine Procarbazine Prednisone Brentuximab Ved... Dacarbazine Dexamethasone | 18 Years - 60 Years | University of Cologne | |
| Study of a-Interferon With Adriamycin, Bleomycin, Velban, and Dacarbazine (ABVD) With Hodgkin's Disease | NCT01404936 | Lymphoma | Interferon-2A Adriamycin Bleomycin Velban Dacarbazine | - | M.D. Anderson Cancer Center | |
| Reduced Dose Radiotherapy Following High Dose Chemotherapy in Intracranial Non-germinomatous Germ Cell Tumor | NCT02784054 | Intracranial No... | Carboplatin Etoposide Cyclophosphamid... Bleomycin Thiotepa Melphalan Reduced dose ra... | 3 Years - 30 Years | Samsung Medical Center | |
| A Trial of Neoadjuvant Chemotherapy + Surgery vs. Surgery for Bulky Stage I/II Cervical Cancer | NCT00190528 | Cervical Neopla... | neoadjuvant che... radical hystere... | 20 Years - 70 Years | Japan Clinical Oncology Group | |
| Chemotherapy With or Without Radiation, Low and Intermediate Risk Hodgkins Lymphoma, TXCH-HD-12A | NCT01858922 | Hodgkin Disease | ABVE-PC DECA | - | Baylor College of Medicine | |
| Reduced Dose Radiotherapy Following High Dose Chemotherapy in Intracranial Non-germinomatous Germ Cell Tumor | NCT02784054 | Intracranial No... | Carboplatin Etoposide Cyclophosphamid... Bleomycin Thiotepa Melphalan Reduced dose ra... | 3 Years - 30 Years | Samsung Medical Center | |
| Study of a-Interferon With Adriamycin, Bleomycin, Velban, and Dacarbazine (ABVD) With Hodgkin's Disease | NCT01404936 | Lymphoma | Interferon-2A Adriamycin Bleomycin Velban Dacarbazine | - | M.D. Anderson Cancer Center | |
| Chemotherapy With or Without Radiation, Low and Intermediate Risk Hodgkins Lymphoma, TXCH-HD-12A | NCT01858922 | Hodgkin Disease | ABVE-PC DECA | - | Baylor College of Medicine | |
| Trial of Drainage With or Without Bleomycin Instillation for Malignant Pericardial Effusion | NCT00132613 | Malignant Peric... | Observation alo... Pericardial ins... | - 75 Years | Japan Clinical Oncology Group | |
| GA In NEwly Diagnosed Diffuse Large B Cell Lymphoma | NCT01659099 | Diffuse Large B... | GA101 Rituximab Doxorubicin Cyclophosphamid... Prednisone Bleomycin Vindesin Vincristine | 18 Years - 60 Years | The Lymphoma Academic Research Organisation | |
| Study Using the Medpulser Electroporation System With Bleomycin to Treat Head and Neck Cancer | NCT00198263 | Head and Neck C... | Medpulser Elect... | 18 Years - | Inovio Pharmaceuticals | |
| Prospective Study on HIV-related Hodgkin Lymphoma | NCT01468740 | HIV-associated ... | Doxorubicin Bleomycin Vinblastine Dacarbazine Etoposide Cyclophosphamid... Vincristine Procarbazine Prednisone | 18 Years - 75 Years | Harlachinger Krebshilfe e.V. | |
| Palliative Treatment of Ulcerated Cutaneous Metastases: Trial Between Electrochemotherapy and Radiotherapy | NCT00918593 | Ulcerated Cutan... | Electrochemothe... Radiotherapy Bleomycin | 18 Years - | Copenhagen University Hospital at Herlev | |
| Brentuximab Vedotin and Nivolumab in Treating Patients With Early Stage Classic Hodgkin Lymphoma | NCT03712202 | Ann Arbor Stage... Ann Arbor Stage... Ann Arbor Stage... Ann Arbor Stage... Ann Arbor Stage... Ann Arbor Stage... Ann Arbor Stage... Ann Arbor Stage... Classic Hodgkin... Lymphocyte-Rich... Ann Arbor Stage... Ann Arbor Stage... Ann Arbor Stage... Ann Arbor Stage... | Bleomycin Brentuximab Ved... Dacarbazine Doxorubicin Nivolumab Quality-of-Life... Vinblastine | 16 Years - | City of Hope Medical Center | |
| HD10 for Early Stages | NCT00265018 | Hodgkin´s Lymph... | Adriamycin Bleomycin Vinblastine DTIC 30 Gy IF-RT 20 Gy IF-RT | 16 Years - 75 Years | University of Cologne | |
| Investigating Cardiovascular Adverse Events Related to Cancer Treatment | NCT03199300 | Toxicity Due to... Cardiovascular ... Cancer, Treatme... | Anthracyclines Trastuzumab Cisplatin Bleomycin | 18 Years - | University Medical Center Groningen | |
| Feasibility and Efficacy of BACOPP-21 for Patients > 60 Years With Intermediate or Advanced Hodgkins Lymphoma | NCT00284271 | Hodgkin´s Lymph... | Cyclophosphamid... Adramycin Procarbacine Prednisone Vincristine Bleomycin Erythropoietin ... | 61 Years - 75 Years | University of Cologne | |
| Rituximab and ABVD for Hodgkin's Patients | NCT00504504 | Lymphoma | Rituximab Adriamycin Bleomycin Vinblastine Dacarbazine (DT... | 16 Years - | M.D. Anderson Cancer Center | |
| Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With Hodgkin's Lymphoma | NCT00003389 | Lymphoma | Doxorubicin Bleomycin Vinblastine Dacarbazine Vincristine Mechlorethamine Etoposide Prednisone Cyclophosphamid... Radiotherapy | 16 Years - | Eastern Cooperative Oncology Group | |
| Treatment of Liver Metastases With Electrochemotherapy (ECTJ) Phase II | NCT02352259 | Liver Metastase... | Electrochemothe... Cliniporator Vi... Bleomycin PHC 1... | 18 Years - | Institute of Oncology Ljubljana | |
| Electrochemotherapy Induces Changes in the Tumor Microenvironment of Cutaneous and Subcutaneous Metastases in Patients With Cutaneous Melanoma | NCT06388252 | Cutaneous Malig... | Electrochemothe... Electrochemothe... | 18 Years - 100 Years | Institute of Oncology Ljubljana | |
| Adjuvant Bleomycin, Etoposide and Cisplatin (BEP) Versus Carboplatin in Stage I Seminomatous Testicular Cancer | NCT02341989 | Testicular Neop... Seminoma | Bleomycin Etopo... Carboplatin | 18 Years - 60 Years | St. Olavs Hospital | |
| Electrochemotherapy on Head and Neck Cancer | NCT02549742 | Head Neck Cance... | Electrochemothe... Cliniporator Bleomycin | 18 Years - | Rigshospitalet, Denmark | |
| Study Comparing ABVD vs BEACOPP in Advanced Hodgkin's Lymphoma | NCT01251107 | Hodgkin Lymphom... | Bleomycin Etoposide Doxorubicin Cyclophosphamid... Vincristine Procarbazine Prednisone Doxorubicin Bleomycin Vinblastine Dacarbazine | 17 Years - 60 Years | Fondazione Michelangelo | |
| Chemotherapy and Azidothymidine, With or Without Radiotherapy, for High Grade Lymphoma in AIDS-Risk Group Members | NCT00000703 | Lymphoma, Non-H... HIV Infections | Bleomycin sulfa... Vincristine sul... Doxorubicin hyd... Cyclophosphamid... Allopurinol Methotrexate Cytarabine Leucovorin calc... Zidovudine Dexamethasone | 19 Years - 69 Years | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Electrochemotherapy as a Palliative Treatment for Brain Metastases | NCT01322100 | Brain Metastase... CNS Metastases | The Electropora... Bleomycin | 18 Years - | Copenhagen University Hospital at Herlev | |
| A Randomized Phase III Clinical Trial of Daunoxome Versus Combination Chemotherapy With Adriamycin/Bleomycin/Vincristine (ABV) in the Treatment of HIV-Associated Kaposi's Sarcoma. | NCT00002093 | Sarcoma, Kaposi HIV Infections | Daunorubicin (l... Bleomycin sulfa... Vincristine sul... Doxorubicin hyd... | 18 Years - | NIH AIDS Clinical Trials Information Service | |
| Treatment of Primary Liver Tumors With Electrochemotherapy (ECT) | NCT02291133 | Liver Cancer | Electrochemothe... Cliniporator Vi... Bleomycin PHC 1... | 18 Years - | University Medical Centre Ljubljana | |
| Phase 2 Study of Rituximab-ABVD in Classical Hodgkin Lymphoma | NCT00369681 | Lymphoma | Bleomycin Rituximab Dacarbazine Doxorubicin Vinblastine | 18 Years - 120 Years | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | |
| GA In NEwly Diagnosed Diffuse Large B Cell Lymphoma | NCT01659099 | Diffuse Large B... | GA101 Rituximab Doxorubicin Cyclophosphamid... Prednisone Bleomycin Vindesin Vincristine | 18 Years - 60 Years | The Lymphoma Academic Research Organisation | |
| Endoscopic Assisted Electrochemotherapy in Addition to Neoadjuvant Treatment of Locally Advanced Rectal Cancer | NCT03040180 | Locally Advance... Electrochemothe... Neoadjuvant The... Down Staging | Electrochemothe... EndoVE | 18 Years - | Zealand University Hospital | |
| A Comparison of DOX-SL Versus Adriamycin Plus Bleomycin Plus Vincristine in the Treatment of Severe AIDS-Related Kaposi's Sarcoma | NCT00002318 | Sarcoma, Kaposi HIV Infections | Doxorubicin hyd... Bleomycin sulfa... Vincristine sul... Doxorubicin hyd... | 18 Years - | NIH AIDS Clinical Trials Information Service | |
| Role of Propranolol as Compared to Bleomycin in Management of Hemangioma | NCT05327309 | Hemangioma Propranolol | Bleomycin | 6 Months - 12 Months | Shaheed Zulfiqar Ali Bhutto Medical University | |
| HD21 for Advanced Stages | NCT02661503 | Classical Hodgk... | Bleomycin Etoposide Doxorubicin Cyclophosphamid... Vincristine Procarbazine Prednisone Brentuximab Ved... Dacarbazine Dexamethasone | 18 Years - 60 Years | University of Cologne | |
| Brentuximab Vedotin as Consolidation Treatment in Patients With Stage I/II HL and PET Positivity After 2 Cycles of ABVD | NCT02298283 | Hodgkin Lymphom... | brentuximab ved... Cyclophosphamid... Adriamycin Oncovin Bleomycin Etoposide Procarbazine Prednisone G-CSF 30 Grays | 18 Years - 65 Years | The Lymphoma Academic Research Organisation | |
| Rituximab and ABVD for Hodgkin's Patients | NCT00504504 | Lymphoma | Rituximab Adriamycin Bleomycin Vinblastine Dacarbazine (DT... | 16 Years - | M.D. Anderson Cancer Center | |
| HD12 for Advanced Stages | NCT00265031 | Hodgkin´s Lymph... | Cyclophosphamid... Adriamycin Etoposide Procarbazine Prednisone Vincristine Bleomycin radiation thera... | 16 Years - 65 Years | University of Cologne | |
| Combination Chemotherapy With or Without Rituximab in Treating Participants With Stage III-IV Classic Hodgkin Lymphoma | NCT00654732 | Classic Hodgkin... Lugano Classifi... Lugano Classifi... | Bleomycin Dacarbazine Doxorubicin Hyd... Rituximab Vinblastine | 17 Years - | M.D. Anderson Cancer Center | |
| Paclitaxel, Ifosfamide and Cisplatin (TIP) Versus Bleomycin, Etoposide and Cisplatin (BEP) for Patients With Previously Untreated Intermediate- and Poor-risk Germ Cell Tumors | NCT01873326 | Germ Cell Tumor... | Paclitaxel Ifosfamide Cisplatin Mesna Bleomycin Etoposide | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Conventional Dose Versus High Dose Sequential Chemotherapy for Poor Prognosis Germ Cell Tumors | NCT02161692 | Testicular Neop... Germ Cell Tumor... | Cyclophosphamid... Etoposide Cisplatin Bleomycin Carboplatin | 18 Years - 75 Years | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | |
| Chemotherapy and Azidothymidine, With or Without Radiotherapy, for High Grade Lymphoma in AIDS-Risk Group Members | NCT00000703 | Lymphoma, Non-H... HIV Infections | Bleomycin sulfa... Vincristine sul... Doxorubicin hyd... Cyclophosphamid... Allopurinol Methotrexate Cytarabine Leucovorin calc... Zidovudine Dexamethasone | 19 Years - 69 Years | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Phase I Study of the Combination of Recombinant GM-CSF, AZT, and Chemotherapy (ABV) (Adriamycin, Bleomycin, Vincristine) in AIDS and Kaposi's Sarcoma | NCT00000681 | Sarcoma, Kaposi HIV Infections | Bleomycin sulfa... Vincristine sul... Doxorubicin hyd... Zidovudine Sargramostim | 14 Years - | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Frontline Therapy Trial in Participants With Advanced Classical Hodgkin Lymphoma | NCT01712490 | Hodgkin Lymphom... | brentuximab ved... doxorubicin bleomycin vinblastine dacarbazine | 18 Years - | Takeda | |
| Chemotherapy Plus Reduced Radiotherapy in Intracranial Germinoma | NCT02782754 | Intracranial Ge... | Carboplatin Etoposide Cyclophosphamid... Bleomycin Reduced dose of... | 3 Years - 30 Years | Samsung Medical Center | |
| A Study to Evaluate the Safety and Efficacy of Amphinex Induced PCI of Bleomycin for Recurrent Head and Neck Cancer. | NCT01606566 | Recurrent Head ... Carcinoma, Squa... | Amphinex induce... | 18 Years - | PCI Biotech AS | |
| Rituximab and ABVD for Hodgkin's Patients | NCT00504504 | Lymphoma | Rituximab Adriamycin Bleomycin Vinblastine Dacarbazine (DT... | 16 Years - | M.D. Anderson Cancer Center | |
| A Phase 1 Study of Brentuximab Vedotin Combined With Multi-Agent Chemotherapy for Hodgkin Lymphoma | NCT01060904 | Disease, Hodgki... | brentuximab ved... doxorubicin vinblastine dacarbazine bleomycin brentuximab ved... | 18 Years - 60 Years | Seagen Inc. | |
| Study of Safety and Efficacy of Pembrolizumab and Chemotherapy in Participants With Newly Diagnosed Classical Hodgkin Lymphoma (cHL) (MK-3475-C11/KEYNOTE-C11) | NCT05008224 | Classical Hodgk... | Pembrolizumab Doxorubicin Vinblastine Dacarbazine Bleomycin Etoposide Cyclophosphamid... Vincristine Procarbazine Prednisone | 18 Years - | Merck Sharp & Dohme LLC | |
| Use of Bleomycin in the Sclerotherapy of Lymphatic Malformations for Pediatric Patients | NCT06437158 | Lymphatic Malfo... | Bleomycin | - 14 Years | West China Hospital | |
| Combination Chemotherapy Plus Low-Dose Radiation Therapy in Treating Patients With Stage I or Stage IIA Hodgkin's Lymphoma | NCT00026208 | Lymphoma, Hodgk... Lymphoma Hodgkin Disease Lymphoma: Hodgk... | Vincristine Cyclophosphamid... Doxorubicin Prednisone Bleomycin Etoposide Low-dose radiot... | 18 Years - 70 Years | Stanford University | |
| A Phase 1 Study of Brentuximab Vedotin Combined With Multi-Agent Chemotherapy for Hodgkin Lymphoma | NCT01060904 | Disease, Hodgki... | brentuximab ved... doxorubicin vinblastine dacarbazine bleomycin brentuximab ved... | 18 Years - 60 Years | Seagen Inc. | |
| TC or BEP in Treating Patients With Malignant Ovarian Germ Cell Tumors | NCT02429687 | Ovarian Germ Ce... Ovarian Neoplas... Ovarian Cancer | Paclitaxel Carboplatin Bleomycin Etoposide Cisplatin | 14 Years - 65 Years | Shandong University | |
| Treatment of Liver Metastases With Electrochemotherapy | NCT01264952 | Liver Metastase... | Electrochemothe... | 18 Years - | Institute of Oncology Ljubljana | |
| Adjuvant Bleomycin, Etoposide and Cisplatin (BEP) Versus Carboplatin in Stage I Seminomatous Testicular Cancer | NCT02341989 | Testicular Neop... Seminoma | Bleomycin Etopo... Carboplatin | 18 Years - 60 Years | St. Olavs Hospital | |
| Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With Hodgkin's Lymphoma | NCT00003389 | Lymphoma | Doxorubicin Bleomycin Vinblastine Dacarbazine Vincristine Mechlorethamine Etoposide Prednisone Cyclophosphamid... Radiotherapy | 16 Years - | Eastern Cooperative Oncology Group | |
| Combination Chemotherapy +/- Radiation in High Risk Hodgkin's Disease | NCT00225173 | Hodgkin Disease | Doxorubicin Vinblastine Cyclophosphamid... Etoposide Vincristine Bleomycin Gemcitabine Vinorelbine Prednisone | 18 Years - 70 Years | Stanford University | |
| R-ACVBP and DA-EPOCH-R in Patients With Non-GCB DLBCL | NCT03018626 | Lymphoma, Large... | Rituximab Etoposide Doxorubicin Vincristine Cyclophosphamid... Prednisone Doxorubicin Cyclophosphamid... Vindesine Bleomycin | 18 Years - 60 Years | Nanfang Hospital, Southern Medical University | |
| Study Using the MedPulser Electroporation System With Bleomycin to Treat Cutaneous and Subcutaneous Cancer | NCT00198276 | Cancer | MedPulser Elect... | 18 Years - | Inovio Pharmaceuticals | |
| A Trial of Neoadjuvant Chemotherapy + Surgery vs. Surgery for Bulky Stage I/II Cervical Cancer | NCT00190528 | Cervical Neopla... | neoadjuvant che... radical hystere... | 20 Years - 70 Years | Japan Clinical Oncology Group | |
| Fludarabine, Mitoxantrone, and Dexamethasone (FND) Plus Rituximab for Lymphoma Patients | NCT00577993 | Lymphoma | Fludarabine Novantrone Decadron Rituximab Interferon Doxorubicin Vincristine Bleomycin Cyclophosphamid... Etoposide Cisplatin Ara-C Methyl-Predniso... Procarbazine Prednisone | - 76 Years | M.D. Anderson Cancer Center | |
| FIL Study on ABVD DD-DI as Upfront Therapy in HL. | NCT03159897 | Hodgkin Lymphom... | Doxorubicin Bleomycin Vinblastine Dacarbazine | 18 Years - 60 Years | Fondazione Italiana Linfomi - ETS | |
| Prospective Study on HIV-related Hodgkin Lymphoma | NCT01468740 | HIV-associated ... | Doxorubicin Bleomycin Vinblastine Dacarbazine Etoposide Cyclophosphamid... Vincristine Procarbazine Prednisone | 18 Years - 75 Years | Harlachinger Krebshilfe e.V. | |
| Medpulser Electroporation With Bleomycin Study to Treat Posterior Head and Neck Squamous Cell Carcinoma | NCT00198328 | Head Neck Cance... | Medpulser Elect... Surgical Excisi... | 18 Years - | Inovio Pharmaceuticals | |
| TC or BEP in Treating Patients With Ovarian Malignant Sex Cord-Stromal Tumors | NCT02429700 | Ovarian Sex Cor... Ovarian Neoplas... Ovarian Cancer | Paclitaxel Carboplatin Bleomycin Etoposide Cisplatin | 14 Years - 65 Years | Shandong University | |
| Dose Escalating Study for Amphinex-based PCI of Bleomycin. | NCT01872923 | Cutaneous or Su... | Amphinex Bleomycin Laser | 18 Years - | PCI Biotech AS | |
| A Frontline Therapy Trial in Participants With Advanced Classical Hodgkin Lymphoma | NCT01712490 | Hodgkin Lymphom... | brentuximab ved... doxorubicin bleomycin vinblastine dacarbazine | 18 Years - | Takeda | |
| Trial of Drainage With or Without Bleomycin Instillation for Malignant Pericardial Effusion | NCT00132613 | Malignant Peric... | Observation alo... Pericardial ins... | - 75 Years | Japan Clinical Oncology Group | |
| Brentuximab Vedotin Associated With Chemotherapy in Untreated Patients With Hodgkin Lymphoma. | NCT02292979 | Hodgkin Lymphom... | Doxorubicin Bleomycin Vinblastine Dacarbazine Brentuximab Ved... | 18 Years - 60 Years | The Lymphoma Academic Research Organisation | |
| R-ACVBP Versus R-CHOP in Patients Aged 60-65 With Diffuse Large B-cell Lymphoma | NCT00135499 | Lymphoma, Large... | Rituximab Doxorubicin Cyclophosphamid... Vindesine Bleomycin Prednisone Prednisone Doxorubicin Cyclophosphamid... Vincristine | 60 Years - 65 Years | Lymphoma Study Association | |
| Chemotherapy With Low-Dose Radiation for Pediatric Hodgkin Lymphoma | NCT00352027 | Hodgkin's Lymph... | Adriamycin® Vinblastine Nitrogen Mustar... Cyclophosphamid... Vincristine Bleomycin Etoposide Prednisone G-CSF Radiotherapy | - 21 Years | St. Jude Children's Research Hospital | |
| A Randomized Phase III Clinical Trial of Daunoxome Versus Combination Chemotherapy With Adriamycin/Bleomycin/Vincristine (ABV) in the Treatment of HIV-Associated Kaposi's Sarcoma. | NCT00002093 | Sarcoma, Kaposi HIV Infections | Daunorubicin (l... Bleomycin sulfa... Vincristine sul... Doxorubicin hyd... | 18 Years - | NIH AIDS Clinical Trials Information Service | |
| Safety Study of Amphinex Based Photochemical Internalisation (PCI) of Bleomycin in Patients With Cutaneous Cancer | NCT00993512 | Head and Neck N... Skin Neoplasms | Amphinex (TPCS2... Bleomycin Illumination wi... | 18 Years - | PCI Biotech AS | |
| Rituximab and ABVD for Hodgkin's Patients | NCT00504504 | Lymphoma | Rituximab Adriamycin Bleomycin Vinblastine Dacarbazine (DT... | 16 Years - | M.D. Anderson Cancer Center | |
| Feasibility and Efficacy of BACOPP-21 for Patients > 60 Years With Intermediate or Advanced Hodgkins Lymphoma | NCT00284271 | Hodgkin´s Lymph... | Cyclophosphamid... Adramycin Procarbacine Prednisone Vincristine Bleomycin Erythropoietin ... | 61 Years - 75 Years | University of Cologne |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
